Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Cash & Equivalents (2023 - 2025)

Ardent Health has reported Cash & Equivalents over the past 3 years, most recently at $709.6 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $709.6 million for Q4 2025, up 27.45% from a year ago — trailing twelve months through Dec 2025 was $709.6 million (up 27.45% YoY), and the annual figure for FY2025 was $709.6 million, up 27.45%.
  • Cash & Equivalents for Q4 2025 was $709.6 million at Ardent Health, up from $609.4 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for ARDT hit a ceiling of $709.6 million in Q4 2025 and a floor of $334.5 million in Q2 2024.
  • Median Cash & Equivalents over the past 3 years was $548.7 million (2024), compared with a mean of $530.8 million.
  • Peak annual rise in Cash & Equivalents hit 61.6% in 2025, while the deepest fall reached 8.22% in 2025.
  • Ardent Health's Cash & Equivalents stood at $437.6 million in 2023, then increased by 27.24% to $556.8 million in 2024, then increased by 27.45% to $709.6 million in 2025.
  • The last three reported values for Cash & Equivalents were $709.6 million (Q4 2025), $609.4 million (Q3 2025), and $540.6 million (Q2 2025) per Business Quant data.